Kathleen Tregoning
Förmögenhet: 87 750 $ per 2026-07-31
Förmögenhet: 87 750 $ per 2026-07-31
Kathleen Tregoning is currently an Independent Director at Spero Therapeutics, Inc. since 2021, an Independent Director at Compass Pathways Plc starting in 2026, and Chief Corporate Affairs Officer at Kailera Therapeutics, Inc. starting in 2026.
Former positions include Member of the United States Congress, Executive Vice President-External Affairs at Sanofi from 2017 to 2020, Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc. from 2020 to 2024, and Senior Vice President-Corporate Affairs at Biogen, Inc. from 2015 to 2017.
Education includes undergraduate studies at Stanford University and graduate studies at Harvard Kennedy School of Government.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC. 0,13 % | 2026-06-23 | 75 000 ( 0,13 % ) | 87 750 $ | 2026-07-31 |
COMPASS PATHWAYS PLC -.--% | 2026-05-27 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2021-10-11 |
| COMPASS PATHWAYS PLC | Direktör/Styrelseledamot | 2026-04-06 |
| Företag | Position | Slut |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Företagsledare/Principal | 2024-08-01 |
| SANOFI | Offentlig kommunikationskontakt | 2020-03-01 |
| BIOGEN INC. | Generell Rådgivare | 2015-12-01 |
United States Congress | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Harvard Kennedy School of Government
Harvard Kennedy School of Government Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Pathways Plc
Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
United States Congress |
Välj din utgåva
All finansiell information anpassad till den nationella nivån